About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials | 6,420 Studies Recruiting

Clinical TrialsColorectal Cancer

Colorectal Cancer Clinical Trials

Browse 6,420 clinical trials for colorectal cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4141-4160 of 6,420 trials

TerminatedSafety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.This is a Phase 1, First-in-Human (FIH), open-label, multicenter, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics and preliminary…NCT05831995·San Francisco, California and 5 others CompletedNelfinavir, a Phase I/Phase II Rectal Cancer StudyThe aim is to study safety and activity of nelfinavir , added to standard chemoradiotherapy in patients with locally advanced rectal cancer.NCT00704600·Maastricht TerminatedSingle Nucleotide Polymorphism(SNP)Study. ICORG 08-40, V4Primary Objective: Correlation of the skin and/or eye toxicity grade secondary to Cetuximab or Panitumumab and the SNP profile of the Epidermal Growth Factor Receptor (EGFR)…NCT01726309·Letterkenny, Donegal and 9 others

Related Searches

colon cancertrials rectal cancertrials

Data from ClinicalTrials.govTerms

CompletedThe Colorectal Breath Analysis (COBRA) StudyThis study aims to determine whether a breath test could be used for early detection of colorectal cancer and colorectal polyps.NCT03699163·London and 7 others

Enrolling by invitationComparison of Efficacy and Safety Between FOLFOX-6 and CAPOX in Metastatic Colorectal CarcinomaThis randomized controlled trial is designed to compare the efficacy and safety of two commonly used chemotherapy regimens, FOLFOX-6 and CAPOX, in adults with metastatic…NCT07334587·Lahore, Punjab Province

UnknownF-18 FDG- PETCT in Staging and Recurrent Colorectal CancerColorectal cancer (CRC) is the fourth most frequently diagnosed cancer and the second leading cause of cancer death in the United States.NCT03572595

CompletedStudy of the Relationship Between Clinical and Paraclinical Markers During Situations of Cachexia and Pre-cachexia in Patients Over 70 Years With Colorectal SurgeryCachexia associated with cancer is a grave and most of the time irreversible common situation. It seems independent from the size of the tumor or from its metastatic character.NCT02199912·Pierre-Bénite

CompletedTrametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by SurgeryThis phase I trial studies the side effects and best dose of trametinib and trifluridine and tipiracil hydrochloride in treating patients with colon or rectal cancer that has…NCT03317119·Corona, California and 7 others

CompletedAn Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ...Objectives: * To find out the maximum tolerated dose of the GI-6207 vaccine (the highest dose that does not cause unacceptable side effects), and to evaluate any side effects.NCT00924092·Bethesda, Maryland

CompletedStudy of Anlotinib in Patients With Metastatic Colorectal Cancer（mCRC）(ALTER0703)The purpose of this study is to compare the effects and safety of Anlotinib with placebo in patients with metastatic colorectal cancer refractory to standard chemotherapies.NCT02332499·Bengbu, Anhui and 28 others

CompletedArginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid TumorsThis study is an open-label Phase 1/Phase 2 evaluation of INCB001158 as a single agent and in combination with immune checkpoint therapy in patients with advanced/metastatic solid…NCT02903914·Mobile, Alabama and 19 others

RecruitingNeoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line TreatmentIn this study, the investigators provide a combined treatment of personalized tumor neoantigen-based peptide vaccine and conventional second-line therapy to patients with…NCT06751914·Nanchang, Jiangxi and 1 other

UnknownPositron Nuclide Labeled DOTA-FAPI PET Study in Colocrectal CancerTo evaluate the normal physiological distribution of positron nuclide labeled DOTA-FAPI PET/CT in human body and its diagnostic efficiency for colorectal cancersNCT04750772·Beijing, Beijing Municipality

Not yet recruitingA Prospective Study of a Subharmonic-Aided Pressure Estimate Technology for Early Prediction of Response to Systemic Therapy in Colorectal Cancer Liver MetastasesColorectal cancer is a common type of cancer that often spreads to the liver. When cancer spreads to the liver, treatment becomes very difficult.NCT07583381

CompletedA Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.The purpose of this study is to assess the antitumor activity of ALIMTA plus Oxaliplatin combination therapy in patients with previously untreated advanced colorectal cancerNCT00034619·Huntsville, Alabama and 21 others

CompletedPattern of Cell Death Following Neoadjuvant Therapy for Metastatic Colon CancerSystemic chemotherapy for metastatic colon cancer is often used in the neoadjuvant setting for patients undergoing liver resection.NCT00414492·Baltimore, Maryland

RecruitingFirst in Human Study of SIM0610 in Solid TumorsThis is a multicenter, open-label, first-in-human (FIH) study to evaluate the safety, tolerability, pharmacokinetic/pharmacodynamic profile, and preliminary antitumor activity of…NCT07348211·Chongqing, Chongqing Municipality and 6 others

Active not recruitingSafety and Performance of the da Vinci SP® Surgical System in Colorectal ProceduresThe study is a prospective, single-center, single-arm unblinded clinical investigation. The aim of this study is to evaluate the performance and safety of da Vinci SP system.NCT05457244·Kaohsiung City

CompletedErbitux Study of CPT11, Oxaliplatin, UFToral Targeted TherapyA Phase II trial to demonstrate the response rate, using the Response evaluation criteria in solid tumours (RECIST) criteria, of patients with locally advanced / metastatic…NCT01225744·Llansantffraid Glan Conwy and 2 others

RecruitingA Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetic, pharmacodynamic, preliminary anti-tumor activity, and to determine the recommended Phase II…NCT07169734·Phoenix, Arizona and 40 others

PreviousPage 208 of 321Next